Dow Jones

39,889.50

0.84%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

SISI

Shineco (SISI)

Shineco Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SISI

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/05/2024	04:14	PR Newswire (US)	Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry	NASDAQ:SISI	Shineco Inc
12/03/2024	15:30	GlobeNewswire Inc.	Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:SISI	Shineco Inc
16/02/2024	15:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SISI	Shineco Inc
14/02/2024	06:00	GlobeNewswire Inc.	Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement	NASDAQ:SISI	Shineco Inc
08/02/2024	15:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SISI	Shineco Inc
16/01/2024	11:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SISI	Shineco Inc
05/01/2024	16:29	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SISI	Shineco Inc
04/01/2024	15:30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:SISI	Shineco Inc
26/12/2023	15:45	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:SISI	Shineco Inc
07/12/2023	15:10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SISI	Shineco Inc
17/11/2023	08:00	GlobeNewswire Inc.	Shineco Announces the Appointment of Two New Executive Officers	NASDAQ:SISI	Shineco Inc
30/10/2023	08:00	GlobeNewswire Inc.	Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition	NASDAQ:SISI	Shineco Inc
04/10/2023	08:00	GlobeNewswire Inc.	Shineco to Increase R&D to Explore New High-Tech Medical Product Applications	NASDAQ:SISI	Shineco Inc
29/09/2023	15:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SISI	Shineco Inc
28/09/2023	15:16	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:SISI	Shineco Inc
29/08/2023	12:26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SISI	Shineco Inc
10/07/2023	08:00	GlobeNewswire Inc.	Shineco Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute Test	NASDAQ:SISI	Shineco Inc
28/06/2023	08:00	GlobeNewswire Inc.	Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company	NASDAQ:SISI	Shineco Inc
27/06/2023	15:45	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SISI	Shineco Inc
16/06/2023	15:32	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:SISI	Shineco Inc
08/06/2023	08:00	GlobeNewswire Inc.	Shineco Subsidiary Registered as a Member of Pharmaceutical Chamber of Commerce	NASDAQ:SISI	Shineco Inc
12/05/2023	15:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SISI	Shineco Inc
04/04/2023	08:00	GlobeNewswire Inc.	Shineco Subsidiary’s ‘Cardiac 5-Minute Test’ Passes Quality Inspection by China Regulator NMPA	NASDAQ:SISI	Shineco Inc
27/02/2023	16:17	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SISI	Shineco Inc
18/01/2023	08:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SISI	Shineco Inc
18/01/2023	08:01	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SISI	Shineco Inc
17/01/2023	08:00	GlobeNewswire Inc.	Shineco Entered Into Framework Agreement Relating to Acquisition of Antiviral Fabric Producer Chongqing Wintus Group	NASDAQ:SISI	Shineco Inc
19/12/2022	08:00	GlobeNewswire Inc.	Shineco, Inc. Subsidiary Receives Prior Approval Supplement from the NMPA Jiangsu Bureau for the Marketing Approval of “Cardiac 5-Minute Test”	NASDAQ:SISI	Shineco Inc
07/12/2022	08:00	GlobeNewswire Inc.	Shineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling Device	NASDAQ:SISI	Shineco Inc
29/11/2022	08:00	GlobeNewswire Inc.	Shineco, Inc. Attends MEDICA 2022 Düsseldorf Germany	NASDAQ:SISI	Shineco Inc